CIRCULATING MICRO-146a AND PRO-INFLAMMATORY CYTOKINES IN PATIENTS WITH CORONARY ARTERY DISEASE WITH TYPE 2 DIABETES MELLITUS

被引：0
|
作者：
Serik, S. [1 ]
Riabukha, V. [1 ]
Malko, V. [1 ]
机构：
[1] Natl Acad Med Sci Ukraine, LT Malaya Therapy Natl Inst, Govt Inst, Dept Ischem Heart Dis & Metab Disorders, Kharkiv, Ukraine
来源：
ATHEROSCLEROSIS | 2022年 / 355卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP517
引用
收藏
页码：E262 / E262
页数：1
相关论文
共 50 条
  • [21] DIFFERENT EFFECTS OF ATORVASTATIN AND ROSUVASTATIN ON CIRCULATING MICRORNAS-126 AND 146A LEVELS IN PATIENTS WITH CORONARY ARTERY DISEASE WITH TYPE 2 DIABETES MELLITUS
    Serik, S.
    Riabukha, V.
    Mavrycheva, N.
    Malko, V.
    Bondar, T.
    ATHEROSCLEROSIS, 2023, 379 : S139 - S140
  • [22] INFLUENCE OF DIET WITH LOW GLYCEMIC INDEX ON PRO-INFLAMMATORY CYTOKINES IN PATIENTS WITH METABOLIC SYNDROME AND CORONARY ARTERY DISEASE
    Uzokov, J.
    Alyavi, B.
    Payziev, D.
    Abdullaev, A.
    Muxitdinova, O.
    ATHEROSCLEROSIS, 2021, 331 : E250 - E250
  • [23] The effect of diabetes mellitus type 2, on endothelial function and inflammatory process in patients with coronary artery disease
    Tousoulis, D
    Antoniades, C
    Vasiliadou, C
    Toutouza, M
    Marinou, K
    Tentolouris, C
    Pitsavos, C
    Vlachopoulos, C
    Tsioufis, C
    Stefanadis, C
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 245A - 245A
  • [24] In Patients with Coronary Artery Disease and Type 2 Diabetes, SIRT1 Expression in Circulating Mononuclear Cells Is Associated with Levels of Inflammatory Cytokines but Not with Coronary Lesions
    Li, Yuanmin
    Ni, Jing
    Guo, Rong
    Li, Weiming
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [25] Analysis of circulating ceramides and hexosylceramides in patients with coronary artery disease and type II diabetes mellitus
    Philip Düsing
    Nadine N. Heinrich
    Baravan Al-Kassou
    Katharina Gutbrod
    Peter Dörmann
    Georg Nickenig
    Felix Jansen
    Andreas Zietzer
    BMC Cardiovascular Disorders, 23
  • [26] Analysis of circulating ceramides and hexosylceramides in patients with coronary artery disease and type II diabetes mellitus
    Duesing, Philip
    Heinrich, Nadine N.
    Al-Kassou, Baravan
    Gutbrod, Katharina
    Doermann, Peter
    Nickenig, Georg
    Jansen, Felix
    Zietzer, Andreas
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [27] Association of circulating CTRP9 with soluble adhesion molecules and inflammatory markers in patients with type 2 diabetes mellitus and coronary artery disease
    Moradi, Nariman
    Fadaei, Reza
    Emamgholipour, Solaleh
    Kazemian, Elham
    Panahi, Ghodratollah
    Vahedi, Siamak
    Saed, Lotfolah
    Fallah, Soudabeh
    PLOS ONE, 2018, 13 (01):
  • [28] EPA and DHA Habitual Intake Is Associated with Pro-Inflammatory Cytokines in Mexican Population with and Without Type 2 Diabetes Mellitus
    Guadarrama-Lopez, A.
    Valdes-Ramos, R.
    Martinez-Carrillo, B.
    Harbige, L.
    ANNALS OF NUTRITION AND METABOLISM, 2018, 73 (03) : 208 - 209
  • [29] Exercise training reduces circulating cytokines in male patients with coronary artery disease and type 2 diabetes: A pilot study
    Garneau, Lea
    Terada, Tasuku
    Mistura, Matheus
    Mulvihill, Erin E.
    Reed, Jennifer L.
    Aguer, Celine
    PHYSIOLOGICAL REPORTS, 2023, 11 (05):
  • [30] Circulating MicroRNA-27a,-221 in Coronary Artery Disease and Type 2 Diabetes Mellitus
    Serik, Serhii A.
    Serdobinska-Kanivets, Emirita M.
    Kurinna, Olena H.
    Tkachenko, Olga V.
    AMERICAN HEART JOURNAL, 2020, 229 : 173 - 174
12345